Search

everythinglearnresearchcommunity

for

Search:↓

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

A special diet can help manage Feline Atopic Skin Syndrome and reduce medication needs in cats.

Alopecia areata significantly affects mental health, especially in women and those with severe cases.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

The tool to measure life quality for women with alopecia is reliable and accurate.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Ixekizumab effectively treats generalized pustular psoriasis.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

A woman's hair grew back while she was taking sulphasalazine for arthritis.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

Baricitinib was effective in treating both early and late onset alopecia areata.

Alopecia areata affects life quality differently based on its severity.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

Alopecia areata significantly worsens quality of life, suggesting a need for mental health support.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

NF-κB levels can help diagnose and assess the severity of androgenetic alopecia.

The study suggests using a score of 11 on the mFG scale to diagnose hirsutism in Turkish women, with adjustments for age, skin type, and family history.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.